Skip to content

Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction

Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction in Peking UNiversity First Hospital: A lonG-term Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06489080
Acronym
SAVING
Enrollment
10000
Registered
2024-07-05
Start date
2024-03-01
Completion date
2028-12-31
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Coronary Artery Disease

Keywords

Acute Myocardial Infarction, Coronary Artery Disease, cohort study

Brief summary

This prospective and prospective cohort study aims to establish a long-term follow-up cohort of patients with acute myocardial infarction, and combine multi-omics studies, wearable devices, artificial intelligence technology, etc., to describe the clinical characteristics of patients with acute myocardial infarction and the changing trend of treatment strategies, and analyze the related influencing factors. Explore new biomarkers and indicators affecting recurrent cardiovascular events for accurate risk stratification and risk prediction; To evaluate the factors affecting lifestyle intervention, drug efficacy and safety, and their impact on outcome, and improve chronic disease management mode, in order to improve the quality of life and prognosis of patients.

Interventions

None listed

Sponsors

Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute myocardial infarction is diagnosed meets the universal definition of acute myocardial infarction

Exclusion criteria

* Did not agree to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Major Adverse Cardiovascular Events5 yearsComposite end points of Cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke

Secondary

MeasureTime frameDescription
Secondary Adverse Cardiovascular Events5 yearsAll-cause death, non-cardiac death, myocardial infarction, hospitalization for coronary revascularization, hospitalization for heart failure, hospitalization for acute coronary syndrome, ischemic stroke, hemorrhagic stroke

Countries

China

Contacts

Primary ContactJia Jia, MPH
jiajia9985@163.com861083572283
Backup ContactBin Zhang, MD
raisend0101@163.com861083572645

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026